Is Blue Jet Healthcare a Good Buy After Its Q1 FY27 Results?
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Market
Blue Jet Healthcare share price around Rs 579. 23.8% below 52-week high of Rs 760. Q1 FY27 revenue Rs 293 crore, down 17.4% YoY. PAT Rs 78 crore, down 14.2%. PE 47x.
Quick Answer
Blue Jet Healthcare’s Q1 FY27 results were mixed, with revenue at Rs 293 crore but PAT falling 14% to Rs 78 crore. The Blue Jet Healthcare share price near Rs 579 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Blue Jet Healthcare is a good buy right now.
The Blue Jet Healthcare share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Blue Jet Healthcare is a manufacturer of pharmaceutical intermediates, contrast media and specialty ingredients, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.
Revenue for the quarter came in at Rs 293 crore, down 17.4% year on year, while profit after tax came in at Rs 78 crore, down 14.2% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Blue Jet Healthcare share price from here.
This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Blue Jet Healthcare share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.
Click Here – Get Free Investment Predictions
Blue Jet Healthcare Q1 FY27 Financial Highlights
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 293 crore | Rs 355 crore | -17.4% |
| Operating Margin | 33.5% | NA | NA |
| Profit Before Tax | Rs 106 crore | Rs 123 crore | -13.8% |
| Net Profit / (Loss) | Rs 78 crore | Rs 91 crore | -14.2% |
Blue Jet Healthcare Q1 FY27 Performance Analysis
Check Blue Jet Healthcare Fundamentals on Univest Screener
Revenue declined 17.4% for the quarter, which was not offset by cost control, and the pharmaceutical intermediates and specialty ingredients manufacturing business will need a stronger showing next quarter to reverse the trend.
Profitability is where the quarter disappointed. PAT fell 14% year on year to Rs 78 crore with revenue also down 17.4%, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Blue Jet Healthcare share price this quarter.
On a sequential basis, revenue moved up 24.9% sequentially from Rs 235 crore in the March 2026 quarter, giving a fuller picture of the trend behind the Blue Jet Healthcare share price than the year on year comparison alone.
Key Business Factors in Q1 FY27
Revenue Trend
Blue Jet Healthcare’s revenue declined 17.4% year on year this quarter, taking the quarterly base to Rs 293 crore in a pharmaceutical intermediates and specialty ingredients manufacturing business that remains sensitive to demand and pricing cycles that ultimately feed through to the Blue Jet Healthcare share price.
Profitability Trend
Profit before tax came in at Rs 106 crore for the quarter, against Rs 123 crore a year earlier, a figure worth tracking alongside the headline PAT number for a fuller picture of the quarter.
Balance Sheet Position
Blue Jet Healthcare’s balance sheet metrics were not fully available for this quarter and should be checked against the company’s official filings before making an investment decision.
Valuation Context
Blue Jet Healthcare does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Blue Jet Healthcare share price.
Dividend Details
No interim dividend was declared alongside Blue Jet Healthcare’s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Blue Jet Healthcare share price for income should watch the company’s announcements around its next annual results for any dividend decision.
Blue Jet Healthcare Share Price Outlook for FY27
The key question for the rest of FY27 is whether Blue Jet Healthcare can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Blue Jet Healthcare share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.
A stabilising or improving margin trend in the next result would be the clearest signal that this quarter’s profit decline was a temporary setback rather than the start of a longer slide for the Blue Jet Healthcare share price.
Blue Jet Healthcare Stock Performance
Download the Univest iOS App or Univest Android App to track Blue Jet Healthcare’s live share price and get daily stock updates.
The Blue Jet Healthcare share price was trading around Rs 579 as results season played out in late August 2026, roughly 23.8% below its 52-week high of Rs 760 and well above its 52-week low of Rs 325.
The Blue Jet Healthcare share price has likely already absorbed some of this quarter’s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off.
Key Risks
Profitability Risk
The quarter’s profit trend is the clearest risk here. Until Blue Jet Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.
Sector and Demand Risk
As a pharmaceutical intermediates and specialty ingredients manufacturing business, Blue Jet Healthcare’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Blue Jet Healthcare share price well before the next result.
Execution Risk
Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
Conclusion
Blue Jet Healthcare’s Q1 FY27 results were weak on both counts, with PAT down 14% to Rs 78 crore, with revenue also falling 17.4%. The Blue Jet Healthcare share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter’s numbers until both the topline and margin trend turn around.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Blue Jet Healthcare Q1 FY27 Results
What were Blue Jet Healthcare’s Q1 FY27 results?
Ans. Blue Jet Healthcare reported Q1 FY27 revenue of Rs 293 crore, down 17.4% year on year, and PAT of Rs 78 crore, down 14.2% year on year.
Is Blue Jet Healthcare a good buy after its Q1 FY27 results?
Ans. Blue Jet Healthcare’s profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.
What is the Blue Jet Healthcare share price today?
Ans. The Blue Jet Healthcare share price was trading around Rs 579 in late August 2026, about 23.8% below its 52-week high of Rs 760 and well above its 52-week low of Rs 325.
What is Blue Jet Healthcare’s revenue and profit for Q1 FY27?
Ans. Blue Jet Healthcare reported revenue of Rs 293 crore and a net profit of Rs 78 crore for the quarter ended June 30, 2026.
Did Blue Jet Healthcare declare a dividend with its Q1 FY27 results?
Ans. No interim dividend was declared alongside Blue Jet Healthcare’s Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.
What is Blue Jet Healthcare’s PE ratio and is it expensive?
Ans. The Blue Jet Healthcare share price trades at a trailing PE of 46.8x. Investors should compare this with the company’s growth rate before judging value.
What are the key risks for Blue Jet Healthcare investors right now?
Ans. The quarter’s profit trend is the clearest risk here. Until Blue Jet Healthcare shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
What is Blue Jet Healthcare’s promoter shareholding?
Ans. Promoter shareholding data for Blue Jet Healthcare was not fully available for this quarter and should be checked on the company’s official filings.
